Stock Price Quote

RANBAXY LABORATORIES LTD.- (AMALGAMATION)

NSE : NABSE : 500359ISIN CODE : INE015A01028Industry : Pharmaceuticals & DrugsHouse : MNC
BSE859.900 (0 %)
PREV CLOSE ( ) 859.90
OPEN PRICE ( ) 814.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 859.90 (10542)
VOLUME 308222
TODAY'S LOW / HIGH ( )810.30 869.00
52 WK LOW / HIGH ( ) 810.3869
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-06 1961
Management Info
Tsutomu Une - Chairman Arun Sawhney - Managing Director
Registered Office

Address A-41, Industrial Area Phase V I I I - A,Sahibzada Ajit Singh Nagar, ,
Mohali,
Punjab-160071

Phone 91-172 6678666

Email secretarial@ranbaxy.com

Website www.ranbaxy.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

26Mar ONGC, Coal India, Praj Industries and
State-run explorer Oil and Natural Gas Corporation (ONGC) has outlined p..
17Mar Ranbaxy Laboratories submits disclosures
Ranbaxy Laboratories has submitted the disclosures under Reg.13(6) of SE..
10Mar Sun Pharma, Ranbaxy and Adani Enterpri
The Punjab & Haryana High Court has given its go-ahead to the $4-bil..
04Mar Ranbaxy loses approval, right to sell
AUS court has upheld the decision by the US Food and Drug Administration..
04Mar Suzlon, APSEZ and Ranbaxy Laboratories
Indian wind turbine maker Suzlon Energy expects to turn profitable in th..

Financials

in Millions
QTR Dec 14 ANNUAL 14
Net Profit-14204.85-8789.95
Gross Profit -5651.35 -8484.25
Operating Profit -4125.921766.24
Net Sales 10098.4968649.37

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  14268.20 (14.14%)
M.Cap ( in Cr)18305.94
Abbott India (BSE)
peergroup  28793.10 (1.48%)
M.Cap ( in Cr)61183.33
Divi's Lab (BSE)
peergroup  6141.15 (3.38%)
M.Cap ( in Cr)163028.24
Mankind Pharma (BSE)
peergroup  2794.40 (4.34%)
M.Cap ( in Cr)111956.00
Lupin (BSE)
peergroup  2223.60 (3.18%)
M.Cap ( in Cr)101428.03

Shareholding Pattern

FI/BANKS/INSURANCE 7.07%
PROMOTERS 63.22%
NON-INSTITUTION 15.61%
FII 12.22%
MUTUAL FUNDS/UTI 1.87%
GOVERNMENT 0%

About Ranbaxy Laboratories Ltd.- (Amalgamation)

Ranbaxy Laboratories Ltd.- (Amalgamation) was incorporated in the year 1961. Its today's share price is 859.9. Its current market capitalisation stands at Rs 36602.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 69089.57 Cr and Total Income of Rs.76497.57 Cr. The company's management includes Sushil K Patawari, Arun Sawhney, Takashi Shoda, Rajesh V Shah, Percy K Shroff, Kazunori Hirokawa, Anthony H Wild, Akihiro Watanabe, Tsutomu Une.

It is listed on the BSE with a BSE Code of 500359 , NSE with an NSE Symbol of RANBAXY and ISIN of INE015A01028. It's Registered office is at A-41, Industrial Area Phase V I I I - A,Sahibzada Ajit Singh Nagar, Mohali-160071, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, Walker, Chandiok & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.